Physician profile
Ryna Then
NPI 1427346303
$789.84
in general payments reported to CMS, 2019-2025
10 companies · $247 in 2025
The $247 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $15.22 · 2022: $61.86 · 2023: $28.28 · 2024: $293 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $224.69 | 2024 | Solitaire X |
| Genentech USA, INC. | $195.13 | 2024-2025 | Ocrevus Zunovo, Ocrevus |
| Penumbra, INC. | $130.90 | 2019 | |
| Philips North America LLC | $104.19 | 2022-2024 | (5044) Mcot |
| Ucb, INC. | $40.96 | 2025 | Fintepla |
| Lundbeck LLC | $25.11 | 2025 | Vyepti |
| Neurelis, INC. | $23.95 | 2025 | Valtoco |
| Abbvie INC. | $15.76 | 2025 | |
| Biogen, INC. | $15.22 | 2020 | |
| Avanir Pharmaceuticals, INC. | $13.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryna Then listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.